CIC
DXCM icon

Carnegie Investment Counsel’s DexCom DXCM Stock Holding History

Carnegie Investment Counsel’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,430
Closed -$231K – 576
2025
Q3 		$231K Sell
3,430
-100
-3% -$7.91K ﹤0.01% 518
2025
Q2 		$308K Hold
3,530
– – 0.01% 468
2025
Q1 		$218K Hold
3,530
– – 0.01% 473
2024
Q4 		$275K Buy
3,530
+350
+11% +$25.9K 0.01% 407
2024
Q3 		$213K Sell
3,180
-2,068
-39% -$170K 0.01% 447
2024
Q2 		$595K Sell
5,248
-100
-2% -$12.6K 0.02% 319
2024
Q1 		$742K Sell
5,348
-62
-1% -$7.79K 0.02% 315
2023
Q4 		$671K Buy
5,410
+1
+0% +$102 0.02% 325
2023
Q3 		$505K Buy
5,409
+60
+1% +$6.76K 0.02% 348
2023
Q2 		$687K Buy
5,349
+34
+0.6% +$4.11K 0.03% 314
2023
Q1 		$617K Sell
5,315
-2
-0% -$224 0.02% 323
2022
Q4 		$602K Buy
5,317
+5
+0.1% +$549 0.03% 328
2022
Q3 		$428K Hold
5,312
– – 0.02% 359
2022
Q2 		$396K Buy
5,312
+420
+9% +$38.3K 0.02% 366
2022
Q1 		$626K Sell
4,892
-356
-7% -$38.9K 0.02% 321
2021
Q4 		$704K Buy
5,248
+568
+12% +$81.6K 0.02% 319
2021
Q3 		$640K Buy
4,680
+948
+25% +$120K 0.02% 290
2021
Q2 		$398K Hold
3,732
– – 0.02% 348
2021
Q1 		$335K Buy
3,732
+140
+4% +$13.1K 0.01% 362
2020
Q4 		$332K Sell
3,592
-200
-5% -$17.9K 0.01% 344
2020
Q3 		$391K Buy
3,792
+1,352
+55% +$141K 0.02% 316
2020
Q2 		$247K Buy
+2,440
New +$218K 0.01% 368

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Carnegie Investment Counsel's DXCM Position: Q4 2025 in Review

Carnegie Investment Counsel sold out of DexCom (DXCM) in Q4 2025, closing a stake of 3,430 shares — an estimated $231K sold.

Carnegie Investment Counsel first reported a position in DXCM in Q2 2020 and held it in 22 quarters. The position peaked at $742K in Q1 2024. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Carnegie Investment Counsel reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Carnegie Investment Counsel sold 3,430 DexCom shares in Q4 2025, an estimated $231K.
  • Carnegie Investment Counsel first reported a position in DexCom in Q2 2020 and held it in 22 quarters.
  • Carnegie Investment Counsel's DexCom position peaked at $742K in Q1 2024.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Carnegie Investment Counsel's 13F filing for Q4 2025, filed 23 Jan 2026.